Emma J. Kooistra - Concepedia

Author

Emma J. Kooistra

Also Known As

E.J. Kooistra, Emma J Kooistra, Emma J. Kooistra, Emma Kooistra, Emma J. Kooistra, Niklas Bruse, Sjef van der Velde, on behalf of the RCI-COVID-19 study group, the RCI-COVID-19 Study Group

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Radboud University Medical Center Radboud University Nijmegen University of Bonn Radboud Institute for Molecular Life Sciences University of Pittsburgh

About

Emma J. Kooistra is an author at Radboud University Medical Center specializing in covid-19, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	476
2	Immunology	4	4	476
3	Public Health	1	1	37
4	Critical Care Medicine	1	1	363
5	Epidemiology	1	1	37

Emma J. Kooistra

Publications

692

Citations

H-Index

Page 1

	Year	Citations
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions Matthijs Kox, Nicole Waalders, Emma J. Kooistra, JAMA InflammationCytokine LevelsCritical Care MedicineCritically Ill PatientsCoronavirus Disease 2019	2020	363
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients Emma J. Kooistra, Miranda van Berkel, N. Kempen, Critical Care	2021	83
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series Arjan van Laarhoven, Lisa Kurver, Gijs J. Overheul, Med MedicineCovid-19 PandemicImmunologyAntiviral ResponseImpaired Cellular Immunity	2021	49
Clinical sepsis phenotypes in critically ill COVID-19 patients Niklas Bruse, Emma J. Kooistra, Aron Jansen, Critical Care	2022	45
Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 Aline de Nooijer, Inge Grondman, Simon Lambden, Bioscience Reports Poor Clinical OutcomesStrem-1 Circulating ConcentrationsImmunologyCovid-19 EpidemiologyCovid-19	2021	37
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19 Martijn Zoodsma, Aline H. de Nooijer, Inge Grondman, Frontiers in Immunology ImmunodeficienciesImmunologyPathologyImmune SystemCovid-19	2022	27
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients Niklas Bruse, Rombout Van Amstel, Eckart De Bie, Intensive Care Medicine	2024	18
Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (<scp>BMI</scp>) on clinical outcomes of <scp>COVID</scp>‐19 patients: A prospective observational study from the Netherlands Aline de Nooijer, Emma J. Kooistra, Inge Grondman, Clinical Obesity	2022	17
Safety and Efficacy of Human Chorionic Gonadotropin Hormone-Derivative EA-230 in Cardiac Surgery Patients: A Randomized Double-Blind Placebo-Controlled Study Roger van Groenendael, Remi Beunders, Pleun Hemelaar, Critical Care Medicine	2021	16
Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19 Amit Frishberg, Emma J. Kooistra, Melanie Nuesch-Germano, Cell Reports Medicine	2022	13

Page 1